BioNTech SE - ADR vs Realty Income Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Realty Income Corp trades at $61.94 (market cap $58.56B). The key difference: Realty Income Corp is far larger — about 2.5× BioNTech SE - ADR's market cap, and Realty Income Corp pays a 5.25% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | O | |
|---|---|---|
Market Cap | $23.31B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $119.34 | $67.56 |
52-Week Low | $83.89 | $55.93 |
Enterprise Value | $6.60B | $89.19B |
Dividend Yield | — | 5.25% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →